LENSAR Dividends and Buybacks

Dividend criteria checks 0/6

LENSAR does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-0.4%

Buyback Yield

Total Shareholder Yield	-0.4%
Future Dividend Yield	n/a
Dividend Growth	n/a
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Payout ratio	n/a

Recent dividend and buyback updates

No updates

Recent updates

We're Hopeful That LENSAR (NASDAQ:LNSR) Will Use Its Cash Wisely

Dec 24

Market Might Still Lack Some Conviction On LENSAR, Inc. (NASDAQ:LNSR) Even After 28% Share Price Boost

Oct 24

LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans

Sep 12

LENSAR, Inc. (NASDAQ:LNSR) Doing What It Can To Lift Shares

Jul 16

Here's Why Shareholders May Want To Be Cautious With Increasing LENSAR, Inc.'s (NASDAQ:LNSR) CEO Pay Packet

May 01

LENSAR, Inc.'s (NASDAQ:LNSR) Shares Leap 33% Yet They're Still Not Telling The Full Story

Feb 22

Here's Why We're Not Too Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation

Nov 01

LENSAR GAAP EPS of -$0.67, revenue of $8M

Aug 08

LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans

Mar 23

We Think LENSAR (NASDAQ:LNSR) Can Afford To Drive Business Growth

Jul 28

LENSAR EPS misses by $0.23, beats on revenue

May 05

What You Need To Know About LENSAR, Inc.'s (NASDAQ:LNSR) Investor Composition

Feb 25

We're Keeping An Eye On LENSAR's (NASDAQ:LNSR) Cash Burn Rate

Jan 03

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if LNSR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if LNSR's dividend payments have been increasing.

Dividend Yield vs Market

LENSAR Dividend Yield vs Market

How does LNSR dividend yield compare to the market?
Segment	Dividend Yield
Company (LNSR)	n/a
Market Bottom 25% (US)	1.4%
Market Top 25% (US)	4.5%
Industry Average (Medical Equipment)	1.8%
Analyst forecast (LNSR) (up to 3 years)	n/a

Notable Dividend: Unable to evaluate LNSR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate LNSR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate LNSR's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as LNSR has not reported any payouts.

Discover strong dividend paying companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 16:58
End of Day Share Price	2024/12/23 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

LENSAR, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Michael Gorman	BTIG
Frank Takkinen	Lake Street Capital Markets, LLC
Richard Newitter	Leerink Partners LLC

LENSAR Dividends and Buybacks

Dividend criteria checks 0/6

Key information

Recent dividend and buyback updates

Recent updates

We're Hopeful That LENSAR (NASDAQ:LNSR) Will Use Its Cash Wisely

Consensus estimates of losses per share improve by 16%

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Forecast to breakeven in 2026

LENSAR, Inc. to Report Q3, 2024 Results on Nov 07, 2024

Market Might Still Lack Some Conviction On LENSAR, Inc. (NASDAQ:LNSR) Even After 28% Share Price Boost

LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans

Consensus EPS estimates fall by 50%

New minor risk - Shareholder dilution

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

New minor risk - Share price stability

LENSAR, Inc. to Report Q2, 2024 Results on Aug 08, 2024

LENSAR, Inc. (NASDAQ:LNSR) Doing What It Can To Lift Shares

First quarter 2024 earnings: EPS exceeds analyst expectations

LENSAR, Inc. to Report Q1, 2024 Results on May 09, 2024

Here's Why Shareholders May Want To Be Cautious With Increasing LENSAR, Inc.'s (NASDAQ:LNSR) CEO Pay Packet

LENSAR, Inc., Annual General Meeting, May 07, 2024

Consensus EPS estimates fall by 42%

Full year 2023 earnings: EPS exceeds analyst expectations

Insufficient new directors

LENSAR, Inc. to Report Q4, 2023 Results on Mar 04, 2024

LENSAR, Inc.'s (NASDAQ:LNSR) Shares Leap 33% Yet They're Still Not Telling The Full Story

Here's Why We're Watching LENSAR's (NASDAQ:LNSR) Cash Burn Situation

Not Many Are Piling Into LENSAR, Inc. (NASDAQ:LNSR) Just Yet

Consensus EPS estimates upgraded to US$1.62 loss, revenue downgraded

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

LENSAR, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Here's Why We're A Bit Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation

New minor risk - Share price stability

LENSAR, Inc. Announces Retirement of John P. McLaughlin from the Board, Effective October 31, 2023

Investors Continue Waiting On Sidelines For LENSAR, Inc. (NASDAQ:LNSR)

Consensus EPS estimates fall by 35%, revenue upgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

New minor risk - Shareholder dilution

LENSAR, Inc. to Report Q2, 2023 Results on Aug 09, 2023

LENSAR, Inc., Annual General Meeting, Aug 01, 2023

Insider recently bought US$85k worth of stock

LENSAR, Inc. announced that it has received $20 million in funding from NR-GRI Partners, LP

First quarter 2023 earnings released: US$0.40 loss per share (vs US$0.67 loss in 1Q 2022)

LENSAR, Inc. to Report Q1, 2023 Results on May 15, 2023

This Broker Just Slashed Their LENSAR, Inc. (NASDAQ:LNSR) Earnings Forecasts

Will LENSAR (NASDAQ:LNSR) Spend Its Cash Wisely?

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased by 20% to US$12.00

Consensus forecasts updated

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

LENSAR, Inc. to Report Q3, 2022 Results on Nov 09, 2022

Here's Why We're Not Too Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation

LENSAR, Inc. Announces First Patients Treated with LENSAR's(R) ALLY(TM) Adaptive Cataract Treatment System

Consensus forecasts updated

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

LENSAR GAAP EPS of -$0.67, revenue of $8M

LENSAR, Inc. to Report Q2, 2022 Results on Aug 08, 2022

LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell Microcap Value Index

LENSAR, Inc. Receives U.S. FDA Clearance of Ally(Tm) Adaptive Cataract Treatment System

Consensus EPS estimates fall by 31%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

LENSAR, Inc. to Report Q1, 2022 Results on May 09, 2022

Price target decreased to US$13.50

Consensus forecasts updated

LENSAR, Inc., Annual General Meeting, May 25, 2022

LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans

Consensus forecasts updated

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

LENSAR, Inc. Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY

LENSAR, Inc. to Report Q4, 2021 Results on Mar 03, 2022

Third quarter 2021 earnings released: US$0.65 loss per share (vs US$0.64 loss in 3Q 2020)

Second quarter 2021 earnings released: US$0.47 loss per share (vs US$4.20 loss in 2Q 2020)

We Think LENSAR (NASDAQ:LNSR) Can Afford To Drive Business Growth

LENSAR, Inc.(NasdaqCM:LNSR) dropped from Russell 2000 Defensive Index

First quarter 2021 earnings released: US$0.56 loss per share (vs US$3.82 loss in 1Q 2020)

LENSAR EPS misses by $0.23, beats on revenue

Full year 2020 earnings released: US$4.28 loss per share (vs US$1.52 loss in FY 2019)

Revenue beats expectations, earnings disappoint

LENSAR, Inc. to Report Q4, 2020 Results on Mar 10, 2021